Takamichi Sugimoto

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 668 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +4

Ultrasonographic Reference Sizes of the Median and Ulnar Nerves and the Cervical Nerve Roots in Healthy Japanese Adults

Takamichi Sugimoto, Kazuhide Ochi, Naohisa Hosomi et al. · Ultrasound in Medicine & Biology · 2013 · 94 citations

Medicine, Anatomy, Neurology +12

Ultrasonographic nerve enlargement of the median and ulnar nerves and the cervical nerve roots in patients with demyelinating Charcot–Marie–Tooth disease: distinction from patients with chronic inflammatory demyelinating polyneuropathy

Takamichi Sugimoto, Kazuhide Ochi, Naohisa Hosomi et al. · Journal of Neurology · 2013 · 90 citations

Medicine, Neurology, Neuropathology +13

Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis

Akiyuki Uzawa, Shigeaki Suzuki, Satoshi Kuwabara et al. · Journal of Neurology Neurosurgery & Psychiatry · 2023 · 49 citations

Medicine, Pharmacology, Pharmacotherapy +13

Japan <scp>MG</scp> registry: Chronological surveys over 10 years

Shigeaki Suzuki, Masayuki Masuda, Akiyuki Uzawa et al. · Clinical and Experimental Neuroimmunology · 2022 · 35 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10